Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

How should we best estimate the mean recency duration for the BED method?

Hargrove J, Eastwood H, Mahiane G, van Schalkwyk C.

PLoS One. 2012;7(11):e49661. doi: 10.1371/journal.pone.0049661. Epub 2012 Nov 16.

2.

HIV incidence determination in the United States: a multiassay approach.

Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH.

J Infect Dis. 2013 Jan 15;207(2):232-9. doi: 10.1093/infdis/jis659. Epub 2012 Nov 5.

3.

Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED.

Ragonnet-Cronin M, Aris-Brosou S, Joanisse I, Merks H, Vallée D, Caminiti K, Rekart M, Krajden M, Cook D, Kim J, Malloch L, Sandstrom P, Brooks J.

J Infect Dis. 2012 Sep 1;206(5):756-64. doi: 10.1093/infdis/jis411. Epub 2012 Jul 23.

4.

Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.

Duong YT, Qiu M, De AK, Jackson K, Dobbs T, Kim AA, Nkengasong JN, Parekh BS.

PLoS One. 2012;7(3):e33328. doi: 10.1371/journal.pone.0033328. Epub 2012 Mar 27.

5.

Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010.

Karlsson A, Björkman P, Bratt G, Ekvall H, Gisslén M, Sönnerborg A, Mild M, Albert J.

PLoS One. 2012;7(3):e33484. doi: 10.1371/journal.pone.0033484. Epub 2012 Mar 20.

6.

Workshop summary: Novel biomarkers for HIV incidence assay development.

Sharma UK, Schito M, Welte A, Rousseau C, Fitzgibbon J, Keele B, Shapiro S, McMichael A, Burns DN.

AIDS Res Hum Retroviruses. 2012 Jun;28(6):532-9. doi: 10.1089/AID.2011.0332. Epub 2012 Feb 24.

7.

Late presentation for HIV diagnosis and care in Germany.

Zoufaly A, an der Heiden M, Marcus U, Hoffmann C, Stellbrink H, Voss L, van Lunzen J, Hamouda O; ClinSurv Study Group.

HIV Med. 2012 Mar;13(3):172-81. doi: 10.1111/j.1468-1293.2011.00958.x. Epub 2011 Nov 7.

8.

Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome.

d'Arminio Monforte A, Cozzi-Lepri A, Girardi E, Castagna A, Mussini C, Di Giambenedetto S, Galli M, Cassola G, Vullo V, Quiros-Roldan E, Lo Caputo S, Antinori A; Icona Foundation Study Group.

Antivir Ther. 2011;16(7):1103-12. doi: 10.3851/IMP1883.

PMID:
22024526
9.

Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines.

Lodi S, Phillips A, Touloumi G, Geskus R, Meyer L, Thiébaut R, Pantazis N, Amo JD, Johnson AM, Babiker A, Porter K; CASCADE Collaboration in EuroCoord.

Clin Infect Dis. 2011 Oct;53(8):817-25. doi: 10.1093/cid/cir494.

10.

More and better information to tackle HIV epidemics: towards improved HIV incidence assays.

Incidence Assay Critical Path Working Group.

PLoS Med. 2011 Jun;8(6):e1001045. doi: 10.1371/journal.pmed.1001045. Epub 2011 Jun 14. No abstract available. Erratum in: PLoS Med. 2011 Jul;8(7). doi:10.1371/annotation/0931760c-95fa-441c-a797-7b410a4c9326. Mastro, Timothy [added].

11.

Designing a genome-based HIV incidence assay with high sensitivity and specificity.

Park SY, Love TM, Nelson J, Thurston SW, Perelson AS, Lee HY.

AIDS. 2011 Oct 23;25(16):F13-9. doi: 10.1097/QAD.0b013e328349f089.

12.

Acute HIV-1 Infection.

Cohen MS, Shaw GM, McMichael AJ, Haynes BF.

N Engl J Med. 2011 May 19;364(20):1943-54. doi: 10.1056/NEJMra1011874. Review. No abstract available.

13.

Estimating the HIV incidence rate: recent and future developments.

Hallett TB.

Curr Opin HIV AIDS. 2011 Mar;6(2):102-7. doi: 10.1097/COH.0b013e328343bfdb. Review.

14.

Stochastic models to demonstrate the effect of motivated testing on HIV incidence estimates using the serological testing algorithm for recent HIV seroconversion (STARHS).

White EW, Lumley T, Goodreau SM, Goldbaum G, Hawes SE.

Sex Transm Infect. 2010 Dec;86(7):506-11. doi: 10.1136/sti.2009.037481. Epub 2010 Nov 8.

15.

Beyond detuning: 10 years of progress and new challenges in the development and application of assays for HIV incidence estimation.

Busch MP, Pilcher CD, Mastro TD, Kaldor J, Vercauteren G, Rodriguez W, Rousseau C, Rehle TM, Welte A, Averill MD, Garcia Calleja JM; WHO Working Group on HIV Incidence Assays.

AIDS. 2010 Nov 27;24(18):2763-71. doi: 10.1097/QAD.0b013e32833f1142. Review. No abstract available.

PMID:
20975514
16.

Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki, Finland.

Skar H, Axelsson M, Berggren I, Thalme A, Gyllensten K, Liitsola K, Brummer-Korvenkontio H, Kivelä P, Spångberg E, Leitner T, Albert J.

J Virol. 2011 Jan;85(1):510-8. doi: 10.1128/JVI.01413-10. Epub 2010 Oct 20.

17.

Cohort profile: the German ClinSurv HIV project--a multicentre open clinical cohort study supplementing national HIV surveillance.

Bätzing-Feigenbaum J, Kollan C, Kühne A, Matysiak-Klose D, Gunsenheimer-Bartmeyer B, Hamouda O; ClinSurv HIV Study Group.

HIV Med. 2011 May;12(5):269-78. doi: 10.1111/j.1468-1293.2010.00879.x. Epub 2010 Oct 18.

18.

Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.

Parekh BS, Hanson DL, Hargrove J, Branson B, Green T, Dobbs T, Constantine N, Overbaugh J, McDougal JS.

AIDS Res Hum Retroviruses. 2011 Mar;27(3):265-73. doi: 10.1089/aid.2010.0159. Epub 2010 Oct 18.

PMID:
20954834
19.

Estimation of the distribution of infection times using longitudinal serological markers of HIV: implications for the estimation of HIV incidence.

Sommen C, Commenges D, Vu SL, Meyer L, Alioum A.

Biometrics. 2011 Jun;67(2):467-75. doi: 10.1111/j.1541-0420.2010.01473.x. Epub 2010 Aug 23.

PMID:
20731647
20.

Late presentation of HIV infection: a consensus definition.

Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, Girardi E, Johnson M, Kirk O, Lundgren J, Mocroft A, D'Arminio Monforte A, Phillips A, Raben D, Rockstroh JK, Sabin C, Sönnerborg A, De Wolf F; European Late Presenter Consensus Working Group.

HIV Med. 2011 Jan;12(1):61-4. doi: 10.1111/j.1468-1293.2010.00857.x.

Items per page

Supplemental Content

Write to the Help Desk